BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
0.9476
+0.0802 (9.25%)
At close: Jun 17, 2026, 4:00 PM EDT
0.9447
-0.0029 (-0.31%)
Pre-market: Jun 18, 2026, 8:26 AM EDT
BioCardia Market Cap
BioCardia has a market cap or net worth of $10.78 million as of June 18, 2026. Its market cap has decreased by -4.51% in one year.
Market Cap
10.78M
Enterprise Value
10.24M
1-Year Change
-4.51%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $10.78M, a decrease of -62.93%. That is a compound annual growth rate of -9.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 10.78M | -18.75% |
| Dec 31, 2025 | 13.27M | 32.74% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 12.39M |
| SeaStar Medical Holding | 12.30M |
| Traws Pharma | 12.10M |
| Kiora Pharmaceuticals | 11.43M |
| Chemomab Therapeutics | 10.84M |
| BioRestorative Therapies | 10.18M |
| Jupiter Neurosciences | 9.97M |
| Intensity Therapeutics | 9.93M |